New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

China New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4, Find details about China Niraparib, Niraparib China from New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

Model NO.
HRK-Niraparib
Product Name
Niraparib Powder
Appearance
White to off- White Crystallinity Powder
Test
HPLC
Mf
C25h32f3n3o4
CAS
1038915-60-4
MW
320.39
Active Ingredient
Niraparib
Sample
Niraparib Avaliable
Certificate
GMP ISO USP Bp
Assay
90% Min
Grade Standard
Feed Grade, Food Grade, Medicine Grade
Application
Vertinary Raw Materials
Type of Product
Auxiliaries and Other Medicinal Chemicals
Storage
Cool Dry Place
Shelf Life
2 Years Proper Storage
Trademark
Henrikang
Transport Package
1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
Specification
99% min Tetramisole HCl
Origin
Shaanxi China
Model NO.
HRK-Niraparib
Product Name
Niraparib Powder
Appearance
White to off- White Crystallinity Powder
Test
HPLC
Mf
C25h32f3n3o4
CAS
1038915-60-4
MW
320.39
Active Ingredient
Niraparib
Sample
Niraparib Avaliable
Certificate
GMP ISO USP Bp
Assay
90% Min
Grade Standard
Feed Grade, Food Grade, Medicine Grade
Application
Vertinary Raw Materials
Type of Product
Auxiliaries and Other Medicinal Chemicals
Storage
Cool Dry Place
Shelf Life
2 Years Proper Storage
Trademark
Henrikang
Transport Package
1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
Specification
99% min Tetramisole HCl
Origin
Shaanxi China
                   New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4
 
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4
Product NameNew Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4
CAS1038915-60-4
AppearanceWhite to off- White crystallinity powder
Molecular formulaC25H32F3N3O4
Molecular Weight320.39
Assay98%
Shelf Life24 months when properly stored
StorageKeep in a cool, dry, dark location
 
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

 
What is Niraparib?

Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.
 

 

Fuction and Application of Niraparib

Niraparib  is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer..
The drug is approved by the US FDA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
 
Product NameCAS No.Product NameCAS No.
Lufenuron103055-07-8Toltrazuril69004-03-1
Nitenpyram120738-89-8Praziquantel/Biltricide55268-74-1
Fenbendazole43210-67-9Tetramisole Hcl5086-74-8
Levamisole14769-73-4Ponazuril9004-4-2
Diclazuril101831-37-2Florfenicol73231-34-2
Ivermectin70288-86-7Enrofloxacin Hcl112732-17-9
Albendazole54965-21-8Mebendazole31431-39-7

Company Information
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4


Our Certificate
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

Our Service
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

Our Research
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

Packaging & Logistics

Package:

1kg per Foil Bag, 10 Bags per carton. 25 kg per Drum. Or Customized Package.
 

2. Shipping Advise: 

1. By Express

------Suitable for under 50kg, Fast:3-4 days. High cost; Door to door service. Easy to pick up the goods.

2. By Air 

------Suitable for more than 50 kg, Fast:4-5 days, High cost, airport to airport. professional broker needed.

3. By sea

------Suitable for more than 500kg. Slow: 15-45 days, Low cost. Port to Port, professional broker needed.

New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4

why choose us ?
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4